MILLENNIUM MANAGEMENT LLC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in LXEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,257,357

+$240,679 QoQ

Shares Held

1,612,780

+77.6% QoQ

Ownership

2.05%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. LXEO ranks #114 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,257,357	1,612,780	+77.6%	Shares	Sole	2026-05-15
2025-12-31	$9,016,678	908,024	-60.8%	Shares	Sole	2026-02-17
2025-09-30	$15,362,582	2,313,642	-18.4%	Shares	Sole	2025-11-14
2025-06-30	$11,401,893	2,836,292	+164.7%	Shares	Sole	2025-08-14
2025-03-31	$3,718,066	1,071,489	+654.8%	Shares	Sole	2025-05-15
2024-12-31	$934,037	141,951	+282.5%	Shares	Sole	2025-02-14
2024-09-30	$335,510	37,114	-0.9%	Shares	Sole	2024-11-14
2024-06-30	$600,954	37,466	-93.7%	Shares	Sole	2024-08-14
2024-03-31	$9,309,560	593,722	+1246.3%	Shares	Sole	2024-05-15
2023-12-31	$591,822	44,100	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.